FDA Drug Recalls

Recalls / Active ingredient / Ezetimibe

Ezetimibe

11 FDA drug recalls involving the active ingredient “Ezetimibe”.

DateClassProductFirm
2025-05-19Class IIIEzetimibe and Simvastatin Tablets, 10mg/40mg, 90-count bottle, Rx only, Manufactured by: Glenmark PharmaceuticGlenmark Pharmaceuticals Inc., USA
2024-03-27Class IIINEXLIZET (bempedoic acid and ezetimibe) tablets, 180 mg/10 mg, 30-count bottle, Rx only, Manufactured for: EspEsperion
2023-08-16Class IIINexlizet (bempedoic acid and ezetimibe), 180ng/18mg, 30 tablets, Rx only, Manufactured for: Esperion TherapeutEsperion
2021-10-14Class IIEzetimibe and Simvastatin Tablets, 10 mg/80mg, 500 tablet bottles, Rx only, Manufactured by Dr. Reddy's LaboraGolden State Medical Supply Inc.
2021-10-14Class IIEzetimibe and Simvastatin Tablets, 10 mg/40mg, a) 90 Tablets, b) 500 tablets, Rx only, Manufactured by Dr. RedGolden State Medical Supply Inc.
2021-10-05Class IIDr. Reddy's Ezetimibe and Simvastatin Tablets, 10 mg/20 mg, a) 30 count (NDC 43598-744-30), b) 90 count (NDC 4Dr. Reddy's Laboratories, Inc.
2021-10-05Class IIDr. Reddy's Ezetimibe and Simvastatin Tablets, 10 mg/40 mg, a) 30 count (NDC 43598-743-30), b) 90 count (NDC 4Dr. Reddy's Laboratories, Inc.
2021-10-05Class IIDr. Reddy's Ezetimibe and Simvastatin Tablets, 10 mg/40 mg, 500 count bottles, Rx Only, Manufactured by: Dr. Dr. Reddy's Laboratories, Inc.
2021-10-05Class IIDr. Reddy's Ezetimibe and Simvastatin Tablets, 10 mg/80 mg, a) 30 count (NDC 43598-745-30), b) 90 count (NDC 4Dr. Reddy's Laboratories, Inc.
2021-10-05Class IIDr. Reddy's Ezetimibe and Simvastatin Tablets, 10 mg/10 mg, a) 90 count (NDC 43598-742-90) and b) 1000 count (Dr. Reddy's Laboratories, Inc.
2021-03-15Class IIEZETIMIBE AND SIMVASTATIN TABLETS 10-10MG 30; NDC/UPC 68462-321-30; RX; TABLETSCardinal Health Inc.